Skip to content
June 20, 2024

Equity.Guru

Investment information for the new generation

Search

Valeo Pharma (VPH.C) – Investor Roundtable #3

Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, we examine once again, Valeo Pharma (VPH.C), a Canadian-based specialty pharma company bringing already approved products from other regions and making them available in the Canadian marketplace. Their therapeutic offerings are in respiratory, oncology, neurology and specialty indications.

Enjoy!

Related Posts

More on

Leave a Reply

Your email address will not be published. Required fields are marked *